[1] Masegosa-Ataz J,Gutiérrez-García ML,Blasco-Algora S,et al.Acute-on-chronic liver failure:Pathogenesis,prognostic factors and management. World J Gastroenterol,2015,21(42):12125-12140. [2] Bernal W.Acute liver failure:review and update. Int Anesthesiol Clin,2017,55(2):92-106. [3] Vatsalya V,Clair H,Falkner KC,et al.Efficacy of keratin 18 (CK18) as a biomarker of severity of liver injury in acute alcoholic hepatitis. Gastroenterology,2017,152(5):S1110-S1111. [4] Mueller S,Nahon P,Rausch V,et al.Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease. Hepatology,2017,66(1):96-107. [5] Yoon HN,Yoon SY,Hong JH,et al.Caspase digestion-resistant homozygous keratin 18 mutation protects mouse liver from apoptosis and injury. J Cell Sci,2017,130(15):2541-2550. [6] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南.实用肝脏病杂志,2013,16(3):210-216. [7] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ. [8] 李晨,游绍莉,刘鸿凌,等. 基线MELD、MELD-Na、iMELD3种模型对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值. 中华危重病急救医学,2014,26(8):539-543. [9] Lin BL,Chen JF,Qiu WH,et al.Allogeneic bone marrow-derived mesenchymal stromal cells for HBV-related acute-on-chronic liver failure:a randomized controlled trial. Hepatology,2017,66(1):209-218. [10] Rao SC,Ashraf I,Mir F,et al.Dual infection with hepatitis B and epstein-barr virus presenting with severe jaundice,coagulopathy,and hepatitis B virus chronicity outcome. Am J of Case Rep,2017,18(2):170-174. [11] Ding G,Li Z,Zhang L,et al.Circulating full-length cytokeratin 18 for predicting prognosis of hepatitis B virus-related acute-on-chronic liver failure patients with lamivudine treatment. Hepat Res,2016,46(4):329-334. [12] Flamm SL,Lim JK,Rubenstein JH,et al.American gastroenterological association institute guidelines for the diagnosis and management of acute liver failure. Gastroenterology,2017,152(3):644-647. [13] Sultana A,Brookesmith M,Ullah S,et al.Prospective evaluation of the International Study Group for Liver Surgery definition of post hepatectomy liver failure after liver resection:an international multicentre study. Hpb,2017,26(1):1-11. [14] Zheng SJ,Liu S,Liu M,et al.Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol,2014,20(9):2403-2411. [15] Kiris T,Avci E,celik A. Combined value of left ventricular ejection fraction and the model for end-stage liver disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention. BMC Cardiovasc Disord,2018,18(1):44-51. [16] Kalafateli M,Mantzoukis K,Yan CY,et al.Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score. J Cachexia Sarcopenia Muscle,2017,8(1):113-121. [17] Roth JA,Widmer AF,Tschudinsutter S,et al.The model for end-stage liver disease(MELD) as a predictor of short-term mortality in staphylococcus aureusbloodstream infection:a single-centre observational study. Plos One,2017,12(4):e0175669. [18] Strnad P,Zhou Q,Hanada S,et al.Keratin variants predispose to acute liver failure and adverse outcome:race and ethnic associations. Gastroenterology,2010,139(3):828-835. [19] Leifeld L,Kothe S,SaHl G,et al. Keratin 18 provides resistance to Fas-mediated liver failure in mice. Eur J Clin Invest,2014,39(6):481-488. [20] 甘巧蓉,张鑫,陈明胜,等. 角蛋白18与乙型肝炎病毒相关慢加急性(亚急性)肝衰竭患者预后的相关性. 中华传染病杂志,2016,34(4):209-214. |